Media coverage
10
Media coverage
Title ATRYS HEALTH S A : The scientific study led by Atrys and Vithas on the impact of Covid-19 is based on technology developed by researchers at Mount Sinai Health System in New York Media name/outlet MarketScreener.com Country/Territory United States Date 25/02/21 URL https://www.marketscreener.com/quote/stock/ATRYS-HEALTH-S-A-105515100/news/Atrys-Health-S-A-The-scientific-study-led-by-Atrys-and-Vithas-on-the-impact-of-Covid-19-is-based-o-32535532/ Persons Carlos Cordon-Cardo, Title Atrys Health S A : The scientific study led by Atrys and Vithas on the impact of Covid-19 is based on technology developed by researchers at Mount Sinai Health System in New York Media name/outlet MarketScreener.com Country/Territory United States Date 25/02/21 URL https://www.marketscreener.com/quote/stock/ATRYS-HEALTH-S-A-105515100/news/Atrys-Health-S-A-The-scientific-study-led-by-Atrys-and-Vithas-on-the-impact-of-Covid-19-is-based-o-32535532/?utm_medium=RSS&utm_content=20210225 Persons Carlos Cordon-Cardo, Title Atrys Health S A : The study led by Atrys and Vithas on the impact of Covid-19 will incorporate an immunological assay from Kantaro Biosciences with technology developed by researchers at Mount Sinai Health System Media name/outlet MarketScreener.com Country/Territory United States Date 25/02/21 URL https://www.marketscreener.com/quote/stock/ATRYS-HEALTH-S-A-105515100/news/Atrys-Health-S-A-The-study-led-by-Atrys-and-Vithas-on-the-impact-of-Covid-19-will-incorporate-an-i-32535597/?utm_medium=RSS&utm_content=20210225 Persons Carlos Cordon-Cardo, Title Atrys Health S A : The study led by Atrys and Vithas on the impact of Covid-19 incorporates an immunological assay from Kantaro Biosciences with technology developed by researchers at Mount Sinai Health System Media name/outlet MarketScreener.com Country/Territory United States Date 25/02/21 URL https://www.marketscreener.com/quote/stock/ATRYS-HEALTH-S-A-105515100/news/Atrys-Health-S-A-The-study-led-by-Atrys-and-Vithas-on-the-impact-of-Covid-19-incorporates-an-immun-32535594/?utm_medium=RSS&utm_content=20210225 Persons Carlos Cordon-Cardo, Title ATRYS HEALTH S A : The study led by Atrys and Vithas on the impact of Covid-19 incorporates an immunological assay from Kantaro Biosciences with technology developed by researchers at Mount Sinai Health System Media name/outlet MarketScreener.com Country/Territory United States Date 25/02/21 URL https://www.marketscreener.com/quote/stock/ATRYS-HEALTH-S-A-105515100/news/Atrys-Health-S-A-The-study-led-by-Atrys-and-Vithas-on-the-impact-of-Covid-19-incorporates-an-immun-32535594/ Persons Carlos Cordon-Cardo, Title ATRYS HEALTH S A : The study led by Atrys and Vithas on the impact of Covid-19 will incorporate an immunological assay from Kantaro Biosciences with technology developed by researchers at Mount Sinai Health System Media name/outlet MarketScreener.com Country/Territory United States Date 25/02/21 URL https://www.marketscreener.com/quote/stock/ATRYS-HEALTH-S-A-105515100/news/Atrys-Health-S-A-The-study-led-by-Atrys-and-Vithas-on-the-impact-of-Covid-19-will-incorporate-an-i-32535597/ Persons Carlos Cordon-Cardo, Title Atrys Health S A : The study led by Atrys and Vithas on the impact of Covid-19 will incorporate an immunological assay from Kantaro Biosciences based on technology developed by researchers at Mount Sinai Health System Media name/outlet MarketScreener.com Country/Territory United States Date 25/02/21 URL https://www.marketscreener.com/quote/stock/ATRYS-HEALTH-S-A-105515100/news/Atrys-Health-S-A-The-study-led-by-Atrys-and-Vithas-on-the-impact-of-Covid-19-will-incorporate-an-i-32535598/?utm_medium=RSS&utm_content=20210225 Persons Carlos Cordon-Cardo, Title ATRYS HEALTH S A : The study led by Atrys and Vithas on the impact of Covid-19 will incorporate an immunological assay from Kantaro Biosciences based on technology developed by researchers at Mount Sinai Health System Media name/outlet MarketScreener.com Country/Territory United States Date 25/02/21 URL https://www.marketscreener.com/quote/stock/ATRYS-HEALTH-S-A-105515100/news/Atrys-Health-S-A-The-study-led-by-Atrys-and-Vithas-on-the-impact-of-Covid-19-will-incorporate-an-i-32535598/ Persons Carlos Cordon-Cardo, Title ATRYS HEALTH S A : The study led by Atrys and Vithas on the impact of Covid-19 incorporates an assay from Kantaro Biosciences with technology developed by researchers at Mount Sinai Health System Media name/outlet MarketScreener.com Country/Territory United States Date 25/02/21 URL https://www.marketscreener.com/quote/stock/ATRYS-HEALTH-S-A-105515100/news/Atrys-Health-S-A-The-study-led-by-Atrys-and-Vithas-on-the-impact-of-Covid-19-incorporates-an-assay-32535652/ Persons Carlos Cordon-Cardo, Title Atrys Health S A : The study led by Atrys and Vithas on the impact of Covid-19 incorporates an assay from Kantaro Biosciences with technology developed by researchers at Mount Sinai Health System Media name/outlet MarketScreener.com Country/Territory United States Date 25/02/21 URL https://www.marketscreener.com/quote/stock/ATRYS-HEALTH-S-A-105515100/news/Atrys-Health-S-A-The-study-led-by-Atrys-and-Vithas-on-the-impact-of-Covid-19-incorporates-an-assay-32535652/?utm_medium=RSS&utm_content=20210225 Persons Carlos Cordon-Cardo,